Authors:
BARKER BF
CARPENTER WM
DANIELS TE
KAHN MA
LEIDER AS
LOZADANUR F
LYNCH DP
MELROSE R
MERRELL P
MORTON T
PETERS E
REGEZI JA
RICHARDS SD
RICK GM
ROHRER MD
SLATER L
STEWART JCB
TOMICH CE
VICKERS RA
WOOD NK
YOUNG SK
Citation: Bf. Barker et al., ORAL MUCOSAL MELANOMAS - THE WESTOP BANFF WORKSHOP PROCEEDINGS, Oral surgery, oral medicine, oral pathology, oral radiology and endodontics, 83(6), 1997, pp. 672-679
Authors:
GUPTILL L
SLATER L
WU CC
LIN TL
GLICKMAN LT
WELCH DF
HOGENESCH H
Citation: L. Guptill et al., EXPERIMENTAL-INFECTION OF YOUNG SPECIFIC PATHOGEN-FREE CATS WITH BARTONELLA-HENSELAE, The Journal of infectious diseases, 176(1), 1997, pp. 206-216
Citation: Ke. Doorduyn et al., MEASURING THE OUTCOMES OF LOW-VISION REHABILITATION, Investigative ophthalmology & visual science, 37(3), 1996, pp. 1385-1385
Citation: J. Cho et al., COLLATERAL SENSITIVITY TO RADIATION AND CISPLATINUM IN A MULTIDRUG-RESISTANT HUMAN LEUKEMIA-CELL LINE, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 168-172
Authors:
SLATER L
SWEET P
WETZEL M
STUPECKY M
OSANN K
Citation: L. Slater et al., COMPARISON OF CYCLOSPORINE-A, VERAPAMIL, PSC-833 AND CREMOPHOR EL AS ENHANCING AGENTS OF VP-16 IN MURINE LYMPHOID LEUKEMIAS, Leukemia research, 19(8), 1995, pp. 543-548
Citation: T. Conley et al., ROCHALIMAEA SPECIES STIMULATE HUMAN ENDOTHELIAL-CELL PROLIFERATION AND MIGRATION IN-VITRO, The Journal of laboratory and clinical medicine, 124(4), 1994, pp. 521-528
Authors:
MANETTA A
BOYLE J
BERMAN ML
DISAIA PJ
LENTZ S
LIAO SY
MUTCH D
SLATER L
Citation: A. Manetta et al., CYCLOSPORINE ENHANCEMENT OF CISPLATIN CHEMOTHERAPY IN PATIENTS WITH REFRACTORY GYNECOLOGIC CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Cancer, 73(1), 1994, pp. 196-199